$TPHS
Trinity Place Holdings Inc.

2024 Q3 Form 10-Q Financial Statement

#000155837024012240 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $397.0K $373.0K
YoY Change -96.27% -94.41%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.418M $2.045M
YoY Change -89.79% -78.27%
Operating Profit -$1.021M -$1.672M
YoY Change -68.52% -38.96%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.021M -$1.672M
YoY Change -91.41% -84.62%
Income Tax $51.00K $54.00K
% Of Pretax Income
Net Earnings -$1.072M -$1.726M
YoY Change -90.98% -84.19%
Net Earnings / Revenue -270.03% -462.73%
Basic Earnings Per Share -$0.02 -$0.03
Diluted Earnings Per Share -$0.02 -$0.03
COMMON SHARES
Basic Shares Outstanding 64.09M 64.05M
Diluted Shares Outstanding 65.79M 65.59M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $505.0K $854.0K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $3.003M $4.467M
YoY Change -98.88% -98.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $1.522M $2.641M
YoY Change -99.43% -99.03%
SHAREHOLDERS EQUITY
Retained Earnings -$89.85M -$88.78M
YoY Change 4.56% 19.9%
Common Stock $150.9M $150.3M
YoY Change 3.59% 3.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.481M $1.826M
YoY Change
Total Liabilities & Shareholders Equity $3.003M $4.467M
YoY Change -98.88% -98.41%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$1.072M -$1.726M
YoY Change -90.98% -84.19%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0000724742
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
1
CY2023Q4 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
1
CY2024Q2 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
1
CY2023Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
1
CY2024Q2 tphs Special Stock Value
SpecialStockValue
CY2023Q4 tphs Special Stock Value
SpecialStockValue
CY2024Q2 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssets
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-08546
dei Entity Registrant Name
EntityRegistrantName
TRINITY PLACE HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-2465228
dei Entity Address Address Line1
EntityAddressAddressLine1
340 Madison Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10173
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
235-2190
dei Security12b Title
Security12bTitle
Common Stock $0.01 Par Value Per Share
dei Trading Symbol
TradingSymbol
TPHS
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64089390
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
62324000
CY2023Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
184561000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
854000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264000
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1643000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8081000
CY2024Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
158000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2774000
CY2024Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1370000
CY2023Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
1370000
CY2024Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0
CY2024Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
125000
CY2023Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
356000
CY2023Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
307000
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
317000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
519000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6952000
CY2024Q2 us-gaap Assets
Assets
4467000
CY2023Q4 us-gaap Assets
Assets
267508000
CY2023Q4 us-gaap Loans Payable
LoansPayable
194628000
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
40791000
CY2023Q4 us-gaap Secured Debt
SecuredDebt
11750000
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
656000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
28273000
CY2024Q2 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
1639000
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
1545000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
346000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
569000
CY2024Q2 us-gaap Liabilities
Liabilities
2641000
CY2023Q4 us-gaap Liabilities
Liabilities
277556000
CY2024Q2 tphs Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2023Q4 tphs Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
1
CY2023Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
1
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
79999997
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
79999997
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71031987
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44965083
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64089390
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38199386
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
711000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
450000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
149575000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
145301000
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6942597
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6765697
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
57665000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
57637000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2017000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2257000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88778000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95905000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1826000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-10048000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4467000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
267508000
CY2023Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1425000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
798000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
2936000
CY2024Q2 us-gaap Other Income
OtherIncome
373000
CY2023Q2 us-gaap Other Income
OtherIncome
24000
us-gaap Other Income
OtherIncome
493000
us-gaap Other Income
OtherIncome
144000
CY2023Q2 tphs Revenue From Sale Of Residential Condominium Units
RevenueFromSaleOfResidentialCondominiumUnits
5224000
tphs Revenue From Sale Of Residential Condominium Units
RevenueFromSaleOfResidentialCondominiumUnits
1439000
tphs Revenue From Sale Of Residential Condominium Units
RevenueFromSaleOfResidentialCondominiumUnits
18321000
CY2024Q2 us-gaap Revenues
Revenues
373000
CY2023Q2 us-gaap Revenues
Revenues
6673000
us-gaap Revenues
Revenues
2730000
us-gaap Revenues
Revenues
21401000
CY2024Q2 tphs Cost Of Property Operating Expenses
CostOfPropertyOperatingExpenses
20000
CY2023Q2 tphs Cost Of Property Operating Expenses
CostOfPropertyOperatingExpenses
811000
tphs Cost Of Property Operating Expenses
CostOfPropertyOperatingExpenses
437000
tphs Cost Of Property Operating Expenses
CostOfPropertyOperatingExpenses
2078000
CY2023Q2 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
451000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
363000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
914000
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1886000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1835000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2992000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3279000
CY2024Q2 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
135000
CY2023Q2 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
143000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
265000
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
287000
CY2023Q2 tphs Cost Of Sale Of Residential Condominium Units
CostOfSaleOfResidentialCondominiumUnits
5169000
tphs Cost Of Sale Of Residential Condominium Units
CostOfSaleOfResidentialCondominiumUnits
1437000
tphs Cost Of Sale Of Residential Condominium Units
CostOfSaleOfResidentialCondominiumUnits
17478000
us-gaap Recapitalization Costs
RecapitalizationCosts
113000
CY2024Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1003000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
766000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2003000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2045000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
9412000
us-gaap Operating Expenses
OperatingExpenses
6260000
us-gaap Operating Expenses
OperatingExpenses
26152000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1672000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2739000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3530000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4751000
tphs Gain Loss On Contribution To Joint Venture
GainLossOnContributionToJointVenture
20976000
tphs Income Loss From Equity Method Investments Excluding Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty
-5962000
tphs Income Loss From Equity Method Investments Excluding Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty
-4000
CY2023Q2 tphs Income Loss From Equity Method Investments Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsGainOnSaleOfProperty
7000
tphs Income Loss From Equity Method Investments Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsGainOnSaleOfProperty
3065000
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
10000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-56000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7194000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3883000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-13522000
CY2023Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
933000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
334000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1825000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1672000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10869000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7267000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16981000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
140000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1726000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10920000
us-gaap Net Income Loss
NetIncomeLoss
7127000
us-gaap Net Income Loss
NetIncomeLoss
-17156000
CY2024Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
120000
CY2023Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
118000
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
240000
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
237000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1606000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10802000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7367000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16919000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.45
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65588000
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65588000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37993000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37993000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59222000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59222000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37800000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37800000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3450000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1726000
CY2024Q2 tphs Shares Issued Value Settlement Of Warrants
SharesIssuedValueSettlementOfWarrants
-94000
CY2024Q2 tphs Shares Issued Value Settlement Of Stock Awards
SharesIssuedValueSettlementOfStockAwards
3000
CY2024Q2 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-120000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1826000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-10048000
us-gaap Net Income Loss
NetIncomeLoss
7127000
tphs Shares Issued Value Settlement Of Warrants
SharesIssuedValueSettlementOfWarrants
4392000
tphs Shares Issued Value Settlement Of Stock Awards
SharesIssuedValueSettlementOfStockAwards
-18000
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-240000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
133000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1826000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
21180000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10920000
CY2023Q2 tphs Shares Issued Value Settlement Of Warrants
SharesIssuedValueSettlementOfWarrants
3000
CY2023Q2 tphs Shares Issued Value Settlement Of Stock Awards
SharesIssuedValueSettlementOfStockAwards
-26000
CY2023Q2 us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-118000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
139000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10494000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
27341000
us-gaap Net Income Loss
NetIncomeLoss
-17156000
tphs Shares Issued Value Settlement Of Warrants
SharesIssuedValueSettlementOfWarrants
3000
tphs Shares Issued Value Settlement Of Stock Awards
SharesIssuedValueSettlementOfStockAwards
-171000
us-gaap Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
-237000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
240000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
10494000
us-gaap Net Income Loss
NetIncomeLoss
7127000
us-gaap Net Income Loss
NetIncomeLoss
-17156000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1100000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3828000
tphs Paid In Kind Interest Cash Flow
PaidInKindInterestCashFlow
-1466000
tphs Paid In Kind Interest Cash Flow
PaidInKindInterestCashFlow
231000
us-gaap Share Based Compensation
ShareBasedCompensation
133000
us-gaap Share Based Compensation
ShareBasedCompensation
233000
tphs Gain On Sale Of Joint Venture Real Estate
GainOnSaleOfJointVentureRealEstate
3065000
tphs Gain Loss On Contribution To Joint Venture
GainLossOnContributionToJointVenture
20976000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-12000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
48000
tphs Reduction Of Claims Liability
ReductionOfClaimsLiability
-240000
tphs Reduction Of Claims Liability
ReductionOfClaimsLiability
-237000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-56000
tphs Income Loss From Equity Method Investments Cash Flow
IncomeLossFromEquityMethodInvestmentsCashFlow
5962000
tphs Income Loss From Equity Method Investments Cash Flow
IncomeLossFromEquityMethodInvestmentsCashFlow
4000
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-2201000
us-gaap Increase Decrease In Assets Held For Sale
IncreaseDecreaseInAssetsHeldForSale
-10386000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
178000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-91000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-176000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1641000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3108000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5956000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5845000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1820000
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
43000
tphs Transfer Of Restricted Cash
TransferOfRestrictedCash
6904000
us-gaap Proceeds From Divestiture Of Interest In Joint Venture
ProceedsFromDivestitureOfInterestInJointVenture
7240000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6904000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7197000
tphs Proceeds From Loans And Corporate Facility
ProceedsFromLoansAndCorporateFacility
2526000
tphs Proceeds From Loans And Corporate Facility
ProceedsFromLoansAndCorporateFacility
3000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
2000000
tphs Repayments Of Loans
RepaymentsOfLoans
14626000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5863000
tphs Settlement Of Stock Awards
SettlementOfStockAwards
18000
tphs Settlement Of Stock Awards
SettlementOfStockAwards
171000
tphs Transfer Of Restricted Cash Financing Activity
TransferOfRestrictedCashFinancingActivity
3000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4393000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6901000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15657000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5848000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6640000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8345000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22055000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2497000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15415000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1548000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8081000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
20507000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8345000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22055000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
854000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4395000
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1643000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
11020000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2497000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15415000
us-gaap Interest Paid Net
InterestPaidNet
915000
us-gaap Interest Paid Net
InterestPaidNet
8870000
us-gaap Income Taxes Paid
IncomeTaxesPaid
117000
us-gaap Income Taxes Paid
IncomeTaxesPaid
120000
tphs Capitalized Amortization Of Deferred Financing Costs And Lease Commissions
CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions
78000
tphs Capitalized Stock Based Compensation Expense
CapitalizedStockBasedCompensationExpense
7000
tphs Transfer Of Real Estate And Condominium Assets Non Cash
TransferOfRealEstateAndCondominiumAssetsNonCash
244477000
tphs Transfer Of Loans Credit Facility And Line Of Credit Non Cash
TransferOfLoansCreditFacilityAndLineOfCreditNonCash
251325000
tphs Transfer Of Assets And Liabilities Net Non Cash
TransferOfAssetsAndLiabilitiesNetNonCash
14797000
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1 – Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Overview</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Trinity Place Holdings Inc., which we refer to in these financial statements as “Trinity,” “we,” “our,” or “us”, is a real estate holding, investment, development and asset management company. As part of a series of transactions described below, o<span style="background:#ffffff;">n February 14, 2024, TPHGreenwich Holdings LLC (“TPHGreenwich”), a previously 100% owned subsidiary of ours, became owned </span><span style="background:#ffffff;">95%</span><span style="background:#ffffff;"> by us, with an affiliate of the lender under our corporate credit facility </span>(the “Corporate Credit Facility” or “CCF”) <span style="background:#ffffff;">owning a </span><span style="background:#ffffff;">5%</span><span style="background:#ffffff;"> interest in, and acting as manager of, such entity.  The entity holds our real estate assets and related liabilities, including (i) the property located at 77 Greenwich Street in Lower Manhattan (“77 Greenwich”), which is substantially complete as a mixed-use project consisting of a 90-unit residential condominium tower, retail space and a New York City elementary school, (ii) a 105-unit, 12-story multi-family property located at 237 11</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup><span style="background:#ffffff;"> Street in Brooklyn, New York (“237 11</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">th</sup><span style="background:#ffffff;">”), and (iii) a property occupied by retail tenants in Paramus, New Jersey (the “Paramus Property”).</span> </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We also control a variety of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. (“Syms”), including FilenesBasement.com, our rights to the Stanley Blacker® brand, as well as the intellectual property associated with the Running of the Brides® event and An Educated Consumer is Our Best Customer® slogan. In addition, we also had approximately $340.1 million of federal net operating loss carryforwards (“NOLs”) and other tax loss carryforwards at June 30, 2024, as well as approximately $362.1 million of various state and local NOLs and other tax loss carryforwards at June 30, 2024, which can be used to reduce our future taxable income and capital gains. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Recapitalization Transactions </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On February 14, 2024, we consummated the transactions contemplated by the Stock <span style="background:#ffffff;">Purchase Agreement, dated as of January 5, 2024 (as amended, the “</span>Stock Purchase Agreement<span style="background:#ffffff;">”), between the Company, TPHS Lender LLC, the lender under the Company’s Corporate Credit Facility (the “</span>Company Investor<span style="background:#ffffff;">”) and TPHS Investor LLC, an affiliate of the Company Investor (the “</span>JV Investor<span style="background:#ffffff;">”, and together with the Company Investor, the “</span>Investor<span style="background:#ffffff;">”), pursuant to which (i) the Company Investor purchased </span><span style="background:#ffffff;">25,112,245</span><span style="background:#ffffff;"> shares of common stock, par value </span><span style="background:#ffffff;">$0.01</span><span style="background:#ffffff;"> per share of the Company (the “</span>Investor Shares<span style="background:#ffffff;">”) for a purchase price of </span><span style="background:#ffffff;">$0.30</span><span style="background:#ffffff;"> per share, (ii) the Company and the JV Investor entered into an amended and restated limited liability company operating agreement of TPHGreenwich (the “</span>JV Operating Agreement<span style="background:#ffffff;">”), pursuant to which the JV Investor was appointed the initial manager of, and acquired a five percent (</span><span style="background:#ffffff;">5%</span><span style="background:#ffffff;">) interest in, TPHGreenwich, as described in more detail below, and TPHGreenwich continues to own, indirectly, all of the real property assets and liabilities of the Company, and (iii) TPHGreenwich entered into an asset management agreement (the “Asset Management Agreement”) with a newly formed subsidiary of the Company (the “TPH Manager”), pursuant to which TPHGreenwich hired the TPH Manager to act as initial asset manager for TPHGreenwich for an annual management fee, as described in more detail below (collectively, the “Recapitalization Transactions”).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Under the Recapitalization Transactions, the real estate assets and related liabilities as well as the Corporate Credit Facility became part of TPHGreenwich, with the Company retaining the substantial federal, state and local tax NOLs and other tax loss carry forwards, intellectual property and a 95% equity interest in TPHGreenwich. In addition, the maturity date of each of the mortgage loan agreement (the “77G Mortgage Loan”) and mezzanine loan agreement (the “77G Mezzanine Loan”) for 77 Greenwich, both of which were assumed by TPHGreenwich, was extended to October 23, 2025 with an option to extend for an additional year, and the maturity date of the Corporate Credit Facility was extended to June 30, 2026.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Joint Venture Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">At the closing of the Recapitalization Transactions, the Company and the JV Investor entered into the JV Operating Agreement, with the Company owning 95% of the ownership interests in TPHGreenwich and the JV Investor owning 5% of the ownership interests in TPHGreenwich. Distributions under the JV Operating Agreement first go to the Investor until the JV Investor has received its initial distribution amount in full (which initial distribution amount is the sum of (v) all amounts due under the CCF and 77G Mezzanine Loan, (w) all amounts due in connection with any additional </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">TPHGreenwich debt financing provided by Investor or its affiliate, (x) Investor’s initial capital contribution, and (y) any additional capital contributions made by Investor), then distributed pro rata pursuant to the members’ respective percentage interests in TPHGreenwich. If TPH Manager is terminated for “Cause” under the Asset Management Agreement, as described below, at the option of Investor, the Company’s right to distributions from TPHGreenwich will be forfeited and any distribution that would otherwise have been made to the Company will instead be distributed to the JV Investor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">JV Investor, in its capacity as manager of TPHGreenwich, will manage, control and conduct the affairs of TPHGreenwich, subject only to certain major decisions set forth in the JV Operating Agreement. Major decisions are (1) entering into any transaction with or for the benefit of Investor or its affiliate, other than any transaction involving Investor or its affiliate providing debt and/or equity to the Company as set forth in the JV Operating Agreement or any arms-length transaction, (2) any amendment or modification of the JV Operating Agreement or any operating agreement of a subsidiary company of TPHGreenwich, or any other agreement with the Company or a subsidiary company of TPHGreenwich if such amendment would materially adversely affect the rights or obligations of the Company in a manner that is disproportionate to the JV Investor, (3) any tax or accounting matter decision relating to net operating losses that would be materially adverse to the Company but not the JV Investor, and (4) the admission of any other member to TPHGreenwich or its subsidiary except as permitted under the JV Operating Agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Under the JV Operating Agreement, the Company will retain oversight of the Paramus Property and will have the sole and exclusive right to manage and make decisions regarding the Paramus Property, subject to (i) the Company Investor’s right to approve any purchase and sale agreement for the Paramus Property that may be entered into in accordance with the terms and conditions of the Stock Purchase Agreement; (ii) the JV Investor’s right to approve any material modifications of such purchase and sale agreement for the Paramus Property, and (iii) the JV Investor’s right to approve any dissolution of the owner of the Paramus Property.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s liability under any cause of action arising from or in connection with the JV Operating Agreement is limited to its interest in TPHGreenwich, other than with respect to certain Company guaranty liabilities related to (a) any loss or expense incurred by the JV Investor under any non-recourse carveout guaranty or environmental indemnity to a third-party lender, or (b) indemnification and reimbursement from the Company if the JV Investor makes a payment to a third party lender pursuant to a guaranty (other than a non-recourse carve out guaranty or environmental indemnity), in each case, to the extent such loss, expense or payment was caused solely by, or required solely as a result of, the acts or omissions of the Company or the TPH Manager without the prior written consent of the JV Investor.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Asset Management Agreement</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At the closing of the Recapitalization Transactions, the TPH Manager entered into the Asset Management Agreement with TPHGreenwich. The Asset Management Agreement provides that the TPH Manager agrees to provide certain services in connection with the construction (with respect to 77 Greenwich), management, operation, supervision and maintenance of 77 Greenwich and 237 11th. To compensate TPH Manager for such services, TPHGreenwich will pay an annual management fee to TPH Manager equal to the greater of (x) $400,000 or (y) 1.25% of (i) the outstanding principal balance of the CCF plus (ii) the outstanding principal balance of the 77G Mezzanine Loan, plus (iii) the principal balance of any future fundings of any type under the CCF and/or 77G Mezzanine Loan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Asset Management Agreement will continue until the earlier to occur of (a) both consummation of a sale, transfer, conveyance or other disposition of 77 Greenwich and 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> and the final resolution of the 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> litigation, or (b) the earlier termination of the Asset Management Agreement pursuant to its terms. TPHGreenwich has the right to terminate the Asset Management Agreement at any time with or without cause, provided that if the TPH Manager is terminated without cause prior to the 18-month anniversary of the Asset Management Agreement, the TPH Manager will be entitled to a termination payment equal to 75 days’ payment of the management fee, based on the average fee paid to the TPH Manager during the immediately prior 12 months. After the 18-month anniversary of the Asset Management Agreement, the TPH Manager will also have the right to terminate the Asset Management Agreement in its sole and absolute discretion, upon not less than 75 days’ prior written notice to TPHGreenwich. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">As described above, if TPH Manager is terminated for “Cause” under the Asset Management Agreement, at the option of Investor, the Company’s right to distributions from TPHGreenwich will be forfeited and any distribution that would otherwise have been made to the Company will instead be distributed to the JV Investor. The term “Cause” means (a) the Company ceasing to be a member under the JV Operating Agreement, (b) TPH Manager transfers its rights or obligations under the Asset Management Agreement in violation of the terms therein, (c) TPH Manager files or consents to a petition </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">in bankruptcy, (d) TPH Manager, any Key Manager Employee (defined below) or any affiliate is convicted of fraud or is determined by a court of competent jurisdiction pursuant to a final judgment to have committed an act of fraud, (e) any misappropriation, gross negligence or willful misconduct by TPH Manager, any Key Manager Employee or any affiliate of the foregoing (which is curable one time during the term of the Asset Management Agreement if committed by a non-senior level employee), (f) any of the Company, TPH Manager or any Key Manager Employee is convicted of a felony crime or crime of moral turpitude, (g) any representation or warranty made by TPH Manager under the Asset Management Agreement is untrue in any material respect and remains uncured after notice from TPHGreenwich, (h) a material breach by TPH Manager of the terms of the Asset Management Agreement (other than as set forth above in this definition) which breach has a material adverse effect on TPHGreenwich and remains uncured after notice from TPHGreenwich, or (i) the breach or failure to comply by TPHGreenwich or any subsidiary with any loan documents (other than, in the case of loan documents in which an affiliate of JV Investor is a lender, with respect to any key person provisions relating to Mr. Messinger, our chief executive officer, or a replacement) in the event such breach or failure is caused by the actions of TPH Manager, Key Manager Employee or any affiliate and continues after the giving of any required notice and the expiration of any applicable cure period under such loan documents, and which is not the subject of a forbearance or waiver from such lender. Under the Asset Management Agreement, “Key Manager Employee” means Mr. Messinger or a replacement officer or employee of TPH Manager with reasonably equivalent skills and abilities (as determined by the JV Investor on behalf of TPHGreenwich in its reasonable discretion). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In the event Mr. Messinger fails to be involved in the day-to-day operations of the TPH Manager pursuant to the Asset Management Agreement, TPHGreenwich agrees its sole and exclusive remedy will be to terminate TPH Manager without cause on 30 days’ notice. As noted below and previously disclosed, Mr. Messinger will be transitioning from CEO of the Company (i.e., TPH Manager) to consultant to TPHGreenwich.  As of June 30, 2024, TPHGreenwich has not terminated the Asset Management Agreement, however there is no assurance of how long the Asset Management Agreement will remain in effect.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">On April 26, 2024, the Company and Mr. Messinger entered into an amendment (the “Amendment”) to Mr. Messinger’s employment agreement, dated as of October 1, 2013, as amended (the “Employment Agreement”), and TPHGreenwich and Mr. Messinger entered into a consulting agreement (the “Consulting Agreement”). Under the Amendment, the Company agreed to make the following payments to Mr. Messinger in exchange for Mr. Messinger’s agreement to continue his employment as chief executive officer of the Company until the later of July 31, 2024 or the filing of the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, unless extended by the parties (the “Termination Date”), and that he will no longer have the right to terminate the Employment Agreement with Good Reason: (i) </span><span style="background:#ffffff;">$300,000</span><span style="background:#ffffff;"> within seven days of execution of the Amendment, (ii) </span><span style="background:#ffffff;">$300,000</span><span style="background:#ffffff;"> on August 1, 2024 and (iii) </span><span style="background:#ffffff;">$300,000</span><span style="background:#ffffff;"> on November 1, 2024. In addition, on the Termination Date, Mr. Messinger’s unvested restricted stock unit grants shall vest, and following the Termination Date, the Company will reimburse Mr. Messinger for COBRA continuation coverage for a period of </span><span style="background:#ffffff;">18 months</span><span style="background:#ffffff;">. These payments, as well as the payments under the Consulting Agreement, will constitute full settlement with regards to any severance payable to Mr. Messinger under the Employment Agreement.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Under the terms of the Amendment, for so long as Mr. Messinger is not in breach of the Amendment or the Consulting Agreement, to the extent that a seat on the Company’s board of directors is then available, until June 30, 2026, the Company Investor will exercise its vote as shareholder in favor of electing Mr. Messinger to the Company’s board of directors, in addition to its existing board appointment rights.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="background:#ffffff;">Upon the Termination Date, the Consulting Agreement will automatically become effective, unless the Employment Agreement is otherwise terminated in accordance with its terms. Under the Consulting Agreement, Mr. Messinger has agreed to provide certain consulting services as an independent contractor to TPHGreenwich related to the properties owned by TPHGreenwich, in exchange for certain consulting payments as follows: upon the earlier to occur of June 1, 2026 and (i) the sale of the Company’s Paramus property, </span><span style="background:#ffffff;">$200,000</span><span style="background:#ffffff;">, (ii) the sale of 237 11</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">th</sup><span style="background:#ffffff;">, located at 237 11</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">th</sup><span style="background:#ffffff;"> Street, Brooklyn, New York, </span><span style="background:#ffffff;">$800,000</span><span style="background:#ffffff;">, (iii) the receipt of the final certificate of occupancy at 77 Greenwich, located at 77 Greenwich Street, New York, New York, </span><span style="background:#ffffff;">$150,000</span><span style="background:#ffffff;">, (iv) the receipt of the agreement by the builder to complete the façade remediation at 77 Greenwich, </span><span style="background:#ffffff;">$150,000</span><span style="background:#ffffff;">, (v) final completion of the façade remediation at 77 Greenwich, </span><span style="background:#ffffff;">$200,000</span><span style="background:#ffffff;"> and (vi) final resolution of the litigation related to the 237 11</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">th</sup><span style="background:#ffffff;"> , </span><span style="background:#ffffff;">$400,000</span><span style="background:#ffffff;">. The timing of the payments is conditioned on the existence of Available Cash (as defined in TPHGreenwich’s operating agreement) sufficient to make such payments; provided that TPHGreenwich must create a special reserve for payment of such amounts using the portion of the proceeds of the sale of the 237 11</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">th</sup><span style="background:#ffffff;"> or 237 11</span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;background:#ffffff;">th</sup><span style="background:#ffffff;"> Litigation distributed to TPHGreenwich by its subsidiaries which constitutes Available Cash. The Consulting Agreement will remain in effect until June 1, 2026, unless sooner terminated in accordance with its terms.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Liquidity and Going Concern; Management’s Plans and Objectives</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Following the Recapitalization Transactions, our primary business is owning approximately $700 million of federal, and various state and local NOLs and other tax loss carryforwards and a variety of intellectual property assets focused on the consumer sector, as well as a 95% interest in TPHGreenwich and acting as asset manager for the properties owned by TPHGreenwich.  We have a limited amount of unrestricted cash and liquidity available for working capital and our cash needs are variable under different circumstances. If the Asset Management Agreement does not remain in place and the related fees are not increased significantly<b style="font-weight:bold;">,</b> the Company’s cash and cash equivalents will not be sufficient to fund the Company’s operations and corporate expenses beyond the next few months, unless we are able to raise additional capital or enter into a strategic transaction, creating substantial doubt about our ability to continue as a going concern.  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">With the Company now unencumbered by its real estate and related liabilities, we continue to focus on exploring a range of strategic and financing alternatives to maximize stockholder value and to engage with parties that have expressed interest in the Company’s attributes and assets and may see the Company as a potential vehicle for growth, with potential opportunities to recapitalize the Company at a lower cost of capital.  The Company engaged Houlihan Lokey and Ackman-Ziff to act as advisors (the “Advisors”) in connection with our strategic review process and to assist us in identifying and evaluating potential alternatives, including among others securing an equity and/or debt financing of the Company, refinancing of existing debt, and/or a sale or merger or reverse merger of the Company. There is no assurance that we will be successful in consummating any such strategic transaction on terms or a timeframe acceptable to us or at all. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The financial statements do not include any adjustments that might result from the outcome of any uncertainty as to our ability to continue as a going concern.</p>
CY2024Q2 tphs Asset Management Annual Management Fee
AssetManagementAnnualManagementFee
400000
CY2024Q2 tphs Asset Management Agreement Minimum Percentage Of Annual Management On Borrowings
AssetManagementAgreementMinimumPercentageOfAnnualManagementOnBorrowings
0.0125
tphs Asset Management Agreement Term Of Agreement Within Which Manager Is Terminated Without Prior Cause To Determine Termination Of Agreement
AssetManagementAgreementTermOfAgreementWithinWhichManagerIsTerminatedWithoutPriorCauseToDetermineTerminationOfAgreement
P18M
tphs Asset Management Agreement Termination Payment Number Of Days Of Management Fee
AssetManagementAgreementTerminationPaymentNumberOfDaysOfManagementFee
P75D
tphs Asset Management Agreement Average Fee Payment Term To Determine Payments Of Termination Management Fee
AssetManagementAgreementAverageFeePaymentTermToDeterminePaymentsOfTerminationManagementFee
P12M
tphs Asset Management Agreement Term After Agreement In Which Manager Has Right To Terminate Agreement
AssetManagementAgreementTermAfterAgreementInWhichManagerHasRightToTerminateAgreement
P18M
tphs Asset Management Agreement Minimum Prior Written Notice Period For Termination Of Agreement By Manager
AssetManagementAgreementMinimumPriorWrittenNoticePeriodForTerminationOfAgreementByManager
P75D
tphs Asset Management Agreement Notice Period To Terminate Manager Without Cause
AssetManagementAgreementNoticePeriodToTerminateManagerWithoutCause
P30D
CY2024Q2 tphs Minimum Amount Of Federal And Various State And Local Net Operating Losses And Variety Of Intellectual Property Assets Focused On Consumer Sector Owned
MinimumAmountOfFederalAndVariousStateAndLocalNetOperatingLossesAndVarietyOfIntellectualPropertyAssetsFocusedOnConsumerSectorOwned
700000000
CY2024Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0
tphs Gain Loss On Contribution To Joint Venture
GainLossOnContributionToJointVenture
21000000.0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.26;text-align:justify;margin:0pt 0pt 0pt 36pt;"><span style="margin-left:0pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">c.    <i style="font-style:italic;">Use of Estimates</i> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates.</p>
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">e.    <i style="font-style:italic;">Concentrations of Credit Risk</i> - Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. We hold substantially all of our cash and cash equivalents in banks. Such cash balances at times exceed federally insured limits.</p>
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
tphs Income Loss From Equity Method Investments Excluding Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty
-5962000
CY2024Q1 tphs Liability For Investment In Unconsolidated Joint Venture
LiabilityForInvestmentInUnconsolidatedJointVenture
0
CY2024Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0
CY2024Q1 us-gaap Liabilities
Liabilities
2713000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87052000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
3450000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6163000
CY2024Q1 tphs Income Loss From Equity Method Investments Excluding Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty
-5962000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8939000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8853000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8973000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
8853000
CY2024Q1 tphs Income Loss From Equity Method Investments Excluding Gain On Sale Of Property
IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty
-5962000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4454000
CY2023Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
51141000
CY2023Q4 us-gaap Tenant Improvements
TenantImprovements
296000
CY2023Q4 us-gaap Fixtures And Equipment Gross
FixturesAndEquipmentGross
943000
CY2023Q4 us-gaap Land And Land Improvements
LandAndLandImprovements
28847000
CY2023Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
81227000
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
18903000
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
62324000
CY2024Q1 us-gaap Depreciation
Depreciation
207000
CY2023Q2 us-gaap Depreciation
Depreciation
692000
us-gaap Depreciation
Depreciation
1400000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11100000
CY2023 tphs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
4100000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
91000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
185000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
370000
CY2024Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
152000
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
1268000
CY2023Q4 tphs Deferred Finance Costs
DeferredFinanceCosts
2184000
CY2024Q2 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
118000
CY2023Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
1793000
CY2024Q2 tphs Prepaid Expense And Other Assets Gross
PrepaidExpenseAndOtherAssetsGross
270000
CY2023Q4 tphs Prepaid Expense And Other Assets Gross
PrepaidExpenseAndOtherAssetsGross
5245000
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
112000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2471000
CY2024Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
158000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2774000
CY2023Q2 us-gaap Interest Costs Incurred
InterestCostsIncurred
7194000
us-gaap Interest Costs Incurred
InterestCostsIncurred
3883000
us-gaap Interest Costs Incurred
InterestCostsIncurred
14211000
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
689000
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7194000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3883000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-13522000
CY2023Q4 us-gaap Defined Benefit Plan Fair Value Of Plan Assets
DefinedBenefitPlanFairValueOfPlanAssets
14200000
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
118000
CY2024Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
118000
us-gaap Operating Lease Expense
OperatingLeaseExpense
235000
us-gaap Operating Lease Expense
OperatingLeaseExpense
235000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
351000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
235000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
116000
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
351000
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5000
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
346000
CY2024Q2 tphs Federal Net Operating Loss Carryforwards Utilized To Date
FederalNetOperatingLossCarryforwardsUtilizedToDate
20100000
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
87900000
CY2024Q2 tphs Capital Stock Shares Authorized
CapitalStockSharesAuthorized
120000000
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
79999997
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
1
CY2024Q2 tphs Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71031987
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44965083
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64089390
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38199386
CY2019Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P10Y
CY2019Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7179000
CY2024Q2 tphs Special Stock Shares Authorized
SpecialStockSharesAuthorized
1
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2041643
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1057824
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
2000000
tphs Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Deferred
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesDeferred
773131
tphs Share Based Compensation Arrangement By Share Based Payment Award Deferred Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredWeightedAverageGrantDateFairValue
0.12
CY2023 tphs Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Deferred
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesDeferred
380484
CY2023 tphs Share Based Compensation Arrangement By Share Based Payment Award Deferred Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardDeferredWeightedAverageGrantDateFairValue
0.50
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
312451
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2041643
CY2024Q2 tphs Deferred Compensation Arrangement With Individual Shares Outstanding
DeferredCompensationArrangementWithIndividualSharesOutstanding
1590745
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001558370-24-012240-index-headers.html Edgar Link pending
0001558370-24-012240-index.html Edgar Link pending
0001558370-24-012240.txt Edgar Link pending
0001558370-24-012240-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tphs-20240630.xsd Edgar Link pending
tphs-20240630x10q.htm Edgar Link pending
tphs-20240630xex10d1.htm Edgar Link pending
tphs-20240630xex10d2.htm Edgar Link pending
tphs-20240630xex31d1.htm Edgar Link pending
tphs-20240630xex31d2.htm Edgar Link pending
tphs-20240630xex32d1.htm Edgar Link pending
tphs-20240630xex32d2.htm Edgar Link pending
tphs-20240630_cal.xml Edgar Link unprocessable
tphs-20240630_def.xml Edgar Link unprocessable
tphs-20240630_lab.xml Edgar Link unprocessable
tphs-20240630_pre.xml Edgar Link unprocessable
tphs-20240630x10q_htm.xml Edgar Link completed